Swedish Orphan Biovitrum AB (SWOBY)
20.95
0.00 (0.00%)
USD |
OTCM |
Sep 18, 16:00
Swedish Orphan Biovitrum Market Cap : 14.55B for Sept. 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 14.55B |
| September 17, 2026 | 14.55B |
| September 16, 2026 | 14.55B |
| September 15, 2026 | 14.73B |
| September 14, 2026 | 15.98B |
| September 11, 2026 | 16.87B |
| September 10, 2026 | 16.87B |
| September 09, 2026 | 16.87B |
| September 08, 2026 | 16.87B |
| September 04, 2026 | 16.87B |
| September 03, 2026 | 16.87B |
| September 02, 2026 | 16.87B |
| September 01, 2026 | 18.06B |
| August 31, 2026 | 18.06B |
| August 28, 2026 | 18.06B |
| August 27, 2026 | 18.06B |
| August 26, 2026 | 16.89B |
| August 25, 2026 | 16.89B |
| August 24, 2026 | 16.89B |
| August 21, 2026 | 16.89B |
| August 20, 2026 | 16.89B |
| August 19, 2026 | 16.89B |
| August 18, 2026 | 16.89B |
| August 17, 2026 | 16.89B |
| August 14, 2026 | 16.89B |
| Date | Value |
|---|---|
| August 13, 2026 | 16.89B |
| August 12, 2026 | 16.89B |
| August 11, 2026 | 16.89B |
| August 10, 2026 | 16.89B |
| August 07, 2026 | 16.89B |
| August 06, 2026 | 16.15B |
| August 05, 2026 | 16.15B |
| August 04, 2026 | 16.15B |
| August 03, 2026 | 16.22B |
| July 31, 2026 | 16.22B |
| July 30, 2026 | 16.32B |
| July 29, 2026 | 16.32B |
| July 28, 2026 | 16.32B |
| July 27, 2026 | 16.32B |
| July 24, 2026 | 16.32B |
| July 23, 2026 | 17.36B |
| July 22, 2026 | 17.36B |
| July 21, 2026 | 17.36B |
| July 20, 2026 | 17.36B |
| July 17, 2026 | 17.36B |
| July 16, 2026 | 17.36B |
| July 15, 2026 | 17.36B |
| July 14, 2026 | 17.36B |
| July 13, 2026 | 17.29B |
| July 10, 2026 | 17.29B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Hansa Biopharma AB | 369.02M |
| BioArctic AB | 3.276B |
| Diamyd Medical AB | 113.14M |
| BONESUPPORT HOLDING AB | 1.600B |
| BioInvent International AB | 216.40M |
Market Cap Related Metrics
| PE Ratio | 96.77 |
| PS Ratio | 4.459 |
| Price to Book Value | 3.332 |
| Price to Free Cash Flow | 29.35 |
| Price | 20.95 |
| Earnings Yield | 1.03% |
| Operating PE Ratio | 14.82 |
| Normalized PE Ratio | 21.04 |